News & Features

The world of MS information changes rapidly. Breakthroughs in understanding the mechanisms of MS, its cause, and its treatment come at a rapid pace. And there's so much to know just about managing the disease in your daily life! 

To keep you informed and up-to-date, MS Focus offers informative periodicals and round-the-clock multimedia broadcasting. Whether print or digital, these materials are designed to be easy to understand for MS patients, their families, and care providers. Subscriptions are free of charge.

Study: MS begins to affect patients sooner than expected

April 21, 2017

People with multiple sclerosis can show signs of something wrong five years before the onset of disease, according to a new analysis of health records from people with the condition
Learn more

MS Focus programs support Spasticity Week

April 10, 2017

MS Focus: the Multiple Sclerosis Foundation will be holding a teleconference and a patient event in support of Spasticity Awareness Week. This year the event will last April 17-21.
Learn more

Researchers target lymph nodes for possible MS treatment

April 04, 2017

In a new study, researchers have developed an experimental treatment that tames the wayward immune system in rodents, returning movement to paralyzed mice. The approach may someday combat multiple sclerosis.
Learn more

Researchers: MicroRNA could hold key to remyelination

March 30, 2017

Scientists partially reinsulated ravaged nerves in mouse models of MS and restored limb mobility by treating the animals with a small non-coding RNA called a microRNA.
Learn more

FDA approves ocrelizumab

March 29, 2017

The U.S. Food and Drug Administration approved Ocrevus (ocrelizumab), made by Genentech, to treat adult patients with relapsing forms of multiple sclerosis and primary progressive multiple sclerosis.
Learn more

Researchers find gene interaction linked with MS risk

March 28, 2017

According to a new study, a person carrying variants of two particular genes could be almost three times more likely to develop multiple sclerosis.
Learn more

Scientists find possible MS, protein link

March 24, 2017

Researchers discovered an entirely new cellular mechanism that may to be linked to multiple sclerosis, and a potential hallmark that may be a target for future treatment.
Learn more

Sail the Caribbean with MS Focus in 2017 and 2018

March 22, 2017

Join MS Focus educational Cruise for a Cause® as we explore exciting and scenic areas in the Caribbean onboard Royal Caribbean Cruise Line's vessels attending one of our many programs presented by MS experts.
Learn more

Researchers suggest T-cell find has remyelination potential

March 20, 2017

Scientists have discovered that specific immune system cells are key players in brain repair.
Learn more

Study: MS begins to affect patients sooner than expected

April 21, 2017

People with multiple sclerosis can show signs of something wrong five years before the onset of disease, according to a new analysis of health records from people with the condition
Learn more

MS Focus programs support Spasticity Week

April 10, 2017

MS Focus: the Multiple Sclerosis Foundation will be holding a teleconference and a patient event in support of Spasticity Awareness Week. This year the event will last April 17-21.
Learn more

Researchers target lymph nodes for possible MS treatment

April 04, 2017

In a new study, researchers have developed an experimental treatment that tames the wayward immune system in rodents, returning movement to paralyzed mice. The approach may someday combat multiple sclerosis.
Learn more

Researchers: MicroRNA could hold key to remyelination

March 30, 2017

Scientists partially reinsulated ravaged nerves in mouse models of MS and restored limb mobility by treating the animals with a small non-coding RNA called a microRNA.
Learn more

FDA approves ocrelizumab

March 29, 2017

The U.S. Food and Drug Administration approved Ocrevus (ocrelizumab), made by Genentech, to treat adult patients with relapsing forms of multiple sclerosis and primary progressive multiple sclerosis.
Learn more

Researchers find gene interaction linked with MS risk

March 28, 2017

According to a new study, a person carrying variants of two particular genes could be almost three times more likely to develop multiple sclerosis.
Learn more

Scientists find possible MS, protein link

March 24, 2017

Researchers discovered an entirely new cellular mechanism that may to be linked to multiple sclerosis, and a potential hallmark that may be a target for future treatment.
Learn more

Sail the Caribbean with MS Focus in 2017 and 2018

March 22, 2017

Join MS Focus educational Cruise for a Cause® as we explore exciting and scenic areas in the Caribbean onboard Royal Caribbean Cruise Line's vessels attending one of our many programs presented by MS experts.
Learn more

Researchers suggest T-cell find has remyelination potential

March 20, 2017

Scientists have discovered that specific immune system cells are key players in brain repair.
Learn more

Red blood cell treatment helps alleviate MS in mice

March 16, 2017

Using red blood cells modified to carry disease-specific antigens, scientists at the Whitehead Institute for Biomedical Research prevented and alleviated multiple sclerosis in early stage mouse models.
Learn more

Fatigue, leg function may help predict disease progression

March 08, 2017

A new study found that in older people with MS, having fatigue and limited leg function is more often seen in people with MS progression than in those without.
Learn more

Cognitive assistive device use for thinking problems related to MS

March 07, 2017

Researchers at Illinois Institute of Technology are conducting a research study investigating use of cognitive assistive devices and aids to help with thinking problems related to multiple sclerosis.
Learn more

Study suggests autoimmune disease, dementia link

March 06, 2017

Autoimmune disease may be linked to a heightened risk of dementia, indicates a large long term study. Although significant, the extent of the association found was small the researchers caution.
Learn more

FDA approves Bioness movement device

March 03, 2017

Bioness Inc. received clearance from the FDA for its NESS L300 Plus System. The NESS L300 Plus is intended for persons with upper motor neuron injury or disease, such as multiple sclerosis.
Learn more

Transcranial stimulation, computer games decrease cognitive symptoms

February 28, 2017

Patients with MS had better problem solving ability and response time after training with a technology called transcranial direct current stimulation (tDCS). The approach may improve quality of life for this patient population.
Learn more

Study: Stem cell treatment can slow, stop MS for up to five years

February 23, 2017

A new study suggests stem cell therapy can slow or stop progression of multiple sclerosis for many years, and the treatment is most effective in people with MS who have 'active inflammation' in their brain and spinal cord.
Learn more

New study finds chronic demyelination, seizure link

February 22, 2017

A new mouse model study helps explain why some patients with multiple sclerosis have seizures. The findings could lead to the development of drugs aimed at reducing seizures in MS.
Learn more

TouchNEUROLOGY makes in-demand Vitamin D resources available online

February 17, 2017

TouchNEUROLOGY, together with the Consortium of MS Centers, have released summaries of a pair of in-demand scientific articles focused on vitamin D and MS. These summaries, which are intended for lay readers, are now available online.
Learn more


Show More News